Makoto Nishizuka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Makoto Nishizuka has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Masayoshi Imagawa
Department of Molecular Biology, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan
6 shared publications Akira Tsukada
1 shared publication- Atsushi Baba
Department of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Japan
1 shared publication Eiko Suzuki
Department of Molecular Biology, Graduate School of Pharmaceutical Sciences, Nagoya City University
1 shared publicationEmi Arimoto
Department of Molecular Biology, Graduate School of Pharmaceutical Sciences, Nagoya City University
1 shared publicationHideyuki Banno
1 shared publication
Latest Publications
- Open Access
- 27 November 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-12
FAD104, a regulator of adipogenesis, is a novel suppressor of TGF-β–mediated EMT in cervical cancer cells
Epithelial-to-mesenchymal transition (EMT) is a biological process in which epithelial cells translate into a mesenchymal phenotype with invasive capacities, contributing to tumour progression, metastasis, and the acquisition of chemotherapy resistance. To identify new therapeutic targets for cancers, it is important to clarify the molecular mechanism of induction of EMT. We have previously reported that fad104, a positive regulator of adipocyte differentiation, suppressed the invasion and metastasis of melanoma and breast cancer cells. In this study, we showed that FAD104 functions as a novel suppressor of transforming growth factor-β (TGF-β)–mediated EMT in cervical cancer cells. Expression of FAD104 is upregulated during TGF-β–mediated EMT in human cervical cancer HeLa cells. Reduction of fad104 expression enhanced TGF-β–mediated EMT and migration in HeLa cells. Conversely, overexpression of FAD104 suppressed TGF-β–induced EMT. In addition, we showed that FAD104 negatively regulated phosphorylation of Smad2 and Smad3 but positively regulated phosphorylation of Smad1/5/8 via treatment with TGF-β. These findings demonstrate that FAD104 is a novel suppressor of TGF-β signalling and represses TGF-β–mediated EMT in cervical cancer cells.
- 27 November 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-12
Open AccessFAD104, a regulator of adipogenesis, is a novel suppressor of TGF-β–mediated EMT in cervical cancer cells
Epithelial-to-mesenchymal transition (EMT) is a biological process in which epithelial cells translate into a mesenchymal phenotype with invasive capacities, contributing to tumour progression, metastasis, and the acquisition of chemotherapy resistance. To identify new therapeutic targets for cancers, it is important to clarify the molecular mechanism of induction of EMT. We have previously reported that fad104, a positive regulator of adipocyte differentiation, suppressed the invasion and metastasis of melanoma and breast cancer cells. In this study, we showed that FAD104 functions as a novel suppressor of transforming growth factor-β (TGF-β)–mediated EMT in cervical cancer cells. Expression of FAD104 is upregulated during TGF-β–mediated EMT in human cervical cancer HeLa cells. Reduction of fad104 expression enhanced TGF-β–mediated EMT and migration in HeLa cells. Conversely, overexpression of FAD104 suppressed TGF-β–induced EMT. In addition, we showed that FAD104 negatively regulated phosphorylation of Smad2 and Smad3 but positively regulated phosphorylation of Smad1/5/8 via treatment with TGF-β. These findings demonstrate that FAD104 is a novel suppressor of TGF-β signalling and represses TGF-β–mediated EMT in cervical cancer cells.
- Open Access
- 9 December 2014
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 15 (12) , 22743-22756
KCNK10, a Tandem Pore Domain Potassium Channel, Is a Regulator of Mitotic Clonal Expansion during the Early Stage of Adipocyte Differentiation
KCNK10, a member of tandem pore domain potassium channel family, gives rise to leak K+ currents. It plays important roles in stabilizing the negative resting membrane potential and in counterbalancing depolarization. We previously demonstrated that kcnk10 expression is quickly elevated during the early stage of adipogenesis of 3T3-L1 cells and that reduction of kcnk10 expression inhibits adipocyte differentiation. However, the molecular mechanism of KCNK10 in adipocyte differentiation remains unclear. Here we revealed that kcnk10 is induced by 3-isobutyl-1-methylxanthine, a cyclic nucleotide phosphodiesterase inhibitor and a potent inducer of adipogenesis, during the early stage of adipocyte differentiation. We also demonstrated that KCNK10 functions as a positive regulator of mitotic clonal expansion (MCE), a necessary process for terminal differentiation. The reduction of kcnk10 expression repressed the expression levels of CCAAT/enhancer-binding protein β (C/EBPβ) and C/EBPδ as well as the phosphorylation level of Akt during the early phase of adipogenesis. In addition, knockdown of kcnk10 expression suppressed insulin-induced Akt phosphorylation. These results indicate that KCNK10 contributes to the regulation of MCE through the control of C/EBPβ and C/EBPδ expression and insulin signaling.
- 9 December 2014
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 15 (12) , 22743-22756
Open AccessKCNK10, a Tandem Pore Domain Potassium Channel, Is a Regulator of Mitotic Clonal Expansion during the Early Stage of Adipocyte Differentiation
KCNK10, a member of tandem pore domain potassium channel family, gives rise to leak K+ currents. It plays important roles in stabilizing the negative resting membrane potential and in counterbalancing depolarization. We previously demonstrated that kcnk10 expression is quickly elevated during the early stage of adipogenesis of 3T3-L1 cells and that reduction of kcnk10 expression inhibits adipocyte differentiation. However, the molecular mechanism of KCNK10 in adipocyte differentiation remains unclear. Here we revealed that kcnk10 is induced by 3-isobutyl-1-methylxanthine, a cyclic nucleotide phosphodiesterase inhibitor and a potent inducer of adipogenesis, during the early stage of adipocyte differentiation. We also demonstrated that KCNK10 functions as a positive regulator of mitotic clonal expansion (MCE), a necessary process for terminal differentiation. The reduction of kcnk10 expression repressed the expression levels of CCAAT/enhancer-binding protein β (C/EBPβ) and C/EBPδ as well as the phosphorylation level of Akt during the early phase of adipogenesis. In addition, knockdown of kcnk10 expression suppressed insulin-induced Akt phosphorylation. These results indicate that KCNK10 contributes to the regulation of MCE through the control of C/EBPβ and C/EBPδ expression and insulin signaling.
- 1 February 2010
- Vol. 68 (2) , 189-93
[PPARgamma target genes and the molecular mechanism of transcriptional control by PPARgamma].
Peroxisome proliferator-activated receptor gamma (PPARgamma) agonist such as thiazolidinedione (TZD) has important roles in inflammation and cancer in addition to the control of energy conservation, adipocyte differentiation and insulin sensitivity. PPARgamma is a ligand-activated nuclear receptor. In the absence of ligand, the transcriptional activity of PPARgamma is suppressed through the association with N-CoR/SMRT and histone deacetylases. Upon binding of ligand to PPARgamma, PPARgamma binds several coactivators and regulates the expression of its target genes in various tissues. To understand various effects of TZD, we summarize the transcriptional control by PPARgamma focused on coactivators and target genes regulated by PPARgamma.
- 1 February 2010
- Vol. 68 (2) , 189-93
[PPARgamma target genes and the molecular mechanism of transcriptional control by PPARgamma].
Peroxisome proliferator-activated receptor gamma (PPARgamma) agonist such as thiazolidinedione (TZD) has important roles in inflammation and cancer in addition to the control of energy conservation, adipocyte differentiation and insulin sensitivity. PPARgamma is a ligand-activated nuclear receptor. In the absence of ligand, the transcriptional activity of PPARgamma is suppressed through the association with N-CoR/SMRT and histone deacetylases. Upon binding of ligand to PPARgamma, PPARgamma binds several coactivators and regulates the expression of its target genes in various tissues. To understand various effects of TZD, we summarize the transcriptional control by PPARgamma focused on coactivators and target genes regulated by PPARgamma.
- 31 December 2009
- Published by Elsevier in Neuroscience Research
- Vol. 65, S200
Function of the C-terminal region of Reelin: a knock-in mouse study
- 31 December 2009
- Published by Elsevier in Neuroscience Research
- Vol. 65, S200
Function of the C-terminal region of Reelin: a knock-in mouse study
- 1 February 2005
- Published by Science Reviews 2000 LTD in Avian and Poultry Biology Reviews
- Vol. 16 (1) , 19-27
In vivo and in vitro Screening of Endocrine Disrupting Chemicals with Estrogenic activity in Japanese Quail
- 1 February 2005
- Published by Science Reviews 2000 LTD in Avian and Poultry Biology Reviews
- Vol. 16 (1) , 19-27
In vivo and in vitro Screening of Endocrine Disrupting Chemicals with Estrogenic activity in Japanese Quail
- 1 January 2004
- Published by Pharmaceutical Society of Japan in Journal of Health Science
- Vol. 50 (6) , 685-688
Evaluation of Ability of Chemicals to Bind Frog (Xenopus laevis) Estrogen Receptor by in Vitro Binding Assay
- 1 January 2004
- Published by Pharmaceutical Society of Japan in Journal of Health Science
- Vol. 50 (6) , 685-688
Evaluation of Ability of Chemicals to Bind Frog (Xenopus laevis) Estrogen Receptor by in Vitro Binding Assay
- 1 January 2004
- Published by Pharmaceutical Society of Japan in Journal of Health Science
- Vol. 50 (3) , 257-263
Isolation of Genes Regulated by Peroxisome Proliferator-Activated Receptor .GAMMA. (PPAR.GAMMA.) by Two-Dimensional Electrophoresis and Mass Spectrometry
- 1 January 2004
- Published by Pharmaceutical Society of Japan in Journal of Health Science
- Vol. 50 (3) , 257-263
Isolation of Genes Regulated by Peroxisome Proliferator-Activated Receptor .GAMMA. (PPAR.GAMMA.) by Two-Dimensional Electrophoresis and Mass Spectrometry
- Open Access
- 1 November 2003
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 123 (11) , 949-956
脂肪細胞分化初期に発現が変動する遺伝子群の単離及び機能解析
Adipocyte differentiation takes place via a complex series of steps. While PPARγ and C/EBPα are known to be master regulators, the events at the earliest stage of adipocyte differentiation are not yet known. In this study, we cloned the genes that are induced at the beginning of the differentiation of 3T3-L1 preadipocyte cells. Of 102 clones obtained, only several clones were already reported as genes that are expressed differentially during adipocyte development. The expression of TCL/TC10βL (TC10-like/TC10βLong) and RGS2 (regulators of G protein signaling 2) genes isolated here rapidly increased after the addition of inducers (insulin, dexamethasone, 3-isobutyl-1-methylxanthine, fetal bovine serum[FBS]). Further, the antisense TCL/TC10βL inhibited the adipogenesis of mouse 3T3-L1 preadipocyte cells, prevented cytoplasmic triglyceride accumulation, and decreased the expression of PPARγ and C/EBPα. Moreover, the constitutive overexpression of TCL/TC10βL or RGS2 in the mouse fibroblast cell line NIH-3T3 results in efficient adipocyte conversion when stimulated with 10% FBS, insulin, 3-isobutyl-1-methylxanthine, dexamethasone, and PPARγ ligand BRL49653. These results strongly suggest that TCL/TC10βL and RGS2 have crucial roles in the program of adipocyte differentiation, probably linked to the PPARγ pathway. Using a subtraction protocol, the genes specifically regulated by TCL/TC10βL were also isolated. The expression pattern of some was similar to TCL/TC10βL expression in adipogenesis, suggesting that these genes are regulated by TCL/TC10βL.
- 1 November 2003
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 123 (11) , 949-956
Open Access脂肪細胞分化初期に発現が変動する遺伝子群の単離及び機能解析
Adipocyte differentiation takes place via a complex series of steps. While PPARγ and C/EBPα are known to be master regulators, the events at the earliest stage of adipocyte differentiation are not yet known. In this study, we cloned the genes that are induced at the beginning of the differentiation of 3T3-L1 preadipocyte cells. Of 102 clones obtained, only several clones were already reported as genes that are expressed differentially during adipocyte development. The expression of TCL/TC10βL (TC10-like/TC10βLong) and RGS2 (regulators of G protein signaling 2) genes isolated here rapidly increased after the addition of inducers (insulin, dexamethasone, 3-isobutyl-1-methylxanthine, fetal bovine serum[FBS]). Further, the antisense TCL/TC10βL inhibited the adipogenesis of mouse 3T3-L1 preadipocyte cells, prevented cytoplasmic triglyceride accumulation, and decreased the expression of PPARγ and C/EBPα. Moreover, the constitutive overexpression of TCL/TC10βL or RGS2 in the mouse fibroblast cell line NIH-3T3 results in efficient adipocyte conversion when stimulated with 10% FBS, insulin, 3-isobutyl-1-methylxanthine, dexamethasone, and PPARγ ligand BRL49653. These results strongly suggest that TCL/TC10βL and RGS2 have crucial roles in the program of adipocyte differentiation, probably linked to the PPARγ pathway. Using a subtraction protocol, the genes specifically regulated by TCL/TC10βL were also isolated. The expression pattern of some was similar to TCL/TC10βL expression in adipogenesis, suggesting that these genes are regulated by TCL/TC10βL.